Skip to main content
. 2020 Jul 19;12(7):1960. doi: 10.3390/cancers12071960
AFTV autologous formalin-fixed tumor vaccine
AHR aryl hydrocarbon receptor
ATRX α-thalassemia/mental retardation X-linked
BRAF v-raf murine sarcoma viral oncogene homolog B1
BRM biological response modifier
CAR chimeric antigen receptor
CMV cytomegalovirus
CSF-1 colony-stimulating factor-1
CTLA-4 cytotoxic T lymphocyte antigen-4
DC dendritic cell
EGFR epidermal growth factor receptor
FOXP3 forkhead box protein P3
GARP glycoprotein A repetitions predominant
GBM glioblastoma
GSC glioma stem cell
ICI immune checkpoint inhibitor
ICM immune checkpoint molecule
IDH isocitrate dehydrogenase
IDO indoleamine 2,3 dioxygenase
IL interleukin
IL-7-hyFc IL-7-hybrid-Fc recombinant protein
KPS Karnofski performance status
LNP lipid nanoparticle
M2Mφ M2-type macrophage
MDSC myeloid-derived suppressor cell
MGMT O6-methylguanine-DNA methyltransferase
MIF macrophage migration inhibitory factor
oHSV oncolytic herpes simplex viruses
PD-1 programmed cell death-1; PD-L1/2 programmed cell death ligand 1/2
PDPN podoplanin
PI3Kγ phosphatidylinositol 3-kinase γ
PRMT 5 protein arginine methyltransferase 5
PMN polymorphonuclear
PTEN phosphatase and tensin homolog
RT radiation therapy
TAM tumor-associated macrophage
TAMC tumor-associated bone marrow cell
TERT telomerase reverse transcriptase
TIL tumor-infiltrated lymphocyte
TIM-3 T-cell immunoglobulin and mucin domain 3
TMZ temozolomide
Treg regulatory T cell
VEGF vascular endothelial growth factor
WHO World Health Organization